Mateus Trinconi Cunha

9PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 19, 2026
Sustained Response to Lorlatinib and Pemetrexed in ALK Fusion-Positive Anaplastic Thyroid Carcinoma With Multiple Distant Metastases: A Case Report.

Matheus Sewastjanow-Silva, Maria E Cabanillas, Eduardo Andreazza Dal Lago

|Jan 31, 2026
Comment on: Fully COVID-19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Mateus Trinconi Cunha, Jennifer Hwang, Priyanka Bhateja

|Nov 18, 2025
Chemotherapy alone for stage II-IVa laryngeal squamous cell carcinoma: A 20-year follow-up.

Mateus Trinconi Cunha, Matheus Sewastjanow-Silva, F Christopher Holsinger

|Jul 29, 2025
CT-Based Radiomics for a priori Predicting Response to Chemoradiation in Locally Advanced Lung Adenocarcinoma.

Erika Z Chung, Laurentius O Osapoetra, Patrick Cheung

|Nov 27, 2023
Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis.

Mateus Trinconi Cunha, Mariana Carvalho Gouveia, Felippe Lazar Neto

|Nov 07, 2023
Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics.

Leonardo G Da Fonseca, Victor Junji Yamamoto, Mateus Trinconi Cunha

Pageof 2

Frequent Collaborators

2 joint publications

Gilberto de Castro Junior

2 joint publications

Renata Ferrarotto

2 joint publications

Matheus Sewastjanow-Silva

1 joint publications

May Tsao